Prof. Angus Dalgleish wrote recently " This is not the end of the issues with the mRNA ‘vaccines’. Several immunology studies have shown that the boosters induce an antibody switch from neutralising subtypes to tolerising subtypes as well as inducing significant T cell suppression, all of which will encourage new infections and suppress the immune response to cancer." [https://www.conservativewoman.co.uk/mrna-vaccines-must-be-banned-once-and-for-all/] However, aside from the toxicity of the LNPs and spike, we see in Image 4 above that the 3rd dose appears to reduce 'turbo cancer' risks at least in part. I believe it is not all antibodies to anything else turn into IgG4, just the anti-spike. Unfortunately it seems this conversion which occurs systemically against the spike protein, doesn't seem to occur in the mucosa, meaning all individuals will still be at increased risk of infection.
For COVID-19 infection spike protein has been detected in blood monocytes (CD16+) for up to 15 months [Patterson BK et al, Frontiers in Immunology, 2022]. No we don't really know how long the changes occur due to vector, especially the SV40 promoter with the nuclear localization signal if integrated into genomic DNA . This is likely to be quite rare (say about 1/250,000) (although not all batches are the same). Dr. Kevin McKernan has a PCR kit that people can buy to test for expression versus integration of the Pfizer vectors. You do not need to have the genome studied beforehand to tell if any of the plasmid sequences or SV40 sequences are there. (The sequence would have to match what is in Pfizer vax). May need to test circulating monocyte/macrophage bone marrow progenitors and stem cells or the cancer cells for these changes. Very few cells in blood but it can be done. On the other hand, can do a 'tumor liquid biopsy' approach for mRNA, cDNA and genomic DNA in plasma. I think the sensitivity could be improved by treating the turbo cancer patient with ivermectin (bolus to rapidly kill lots of turbo cancer cells and the nucleotides released would be in the blood, test a few samples day 1-7, 10 and 15 days to see what day is optimal). Can validate the methodology in a person recently injected with Pfizer C19 vaccine. There is a call to try to raise $$$ to support these investigations (see comments in my last post).
Prof. Angus Dalgleish wrote recently " This is not the end of the issues with the mRNA ‘vaccines’. Several immunology studies have shown that the boosters induce an antibody switch from neutralising subtypes to tolerising subtypes as well as inducing significant T cell suppression, all of which will encourage new infections and suppress the immune response to cancer." [https://www.conservativewoman.co.uk/mrna-vaccines-must-be-banned-once-and-for-all/] However, aside from the toxicity of the LNPs and spike, we see in Image 4 above that the 3rd dose appears to reduce 'turbo cancer' risks at least in part. I believe it is not all antibodies to anything else turn into IgG4, just the anti-spike. Unfortunately it seems this conversion which occurs systemically against the spike protein, doesn't seem to occur in the mucosa, meaning all individuals will still be at increased risk of infection.
Dr. William Makis also recommends investigating Fenbendazole as a cancer treatment; expected to be similar to ivermectin. https://makismd.substack.com/p/fenbendazole-and-cancer-at-least?utm_source=profile&utm_medium=reader2
🙏 Brilliant article, so much information.
Just recently watched Dr Makis being interviewed on The Highwire about turbo cancers.
I did a quick analysis of cancer reports to VAERS almost a year ago (https://www.trialsitenews.com/a/are-covid-19-vaccine-induced-cancers-rare-events-806312db). Didn't focus on turbo cancers, only numbers of events. I didn't expect to find much, since the latency period of many cancers can be decades, while the COVID-19 shots had been out for ~two years. Unfortunately, quite a few cancer events were reported to VAERS. A later study outlined more mechanisms that could increase the chances for cancer, and addressed turbo cancer to a minor extent (https://www.trialsitenews.com/a/is-the-covid-19-vaccine-a-bioweapon-c778c1d4). Another study focused on protection against carcinogens in the workplace, including the COVID-19 shots (https://www.trialsitenews.com/a/how-well-is-the-american-worker-protected-against-carcinogens-f84b87de), and a fourth study focused on the absence of clinical trials for alternative cancer therapies (https://www.trialsitenews.com/a/where-are-clinical-trials-for-alternative-cancer-therapies-d0b3365e). The final study I will mention went on line a few weeks ago, and had strong emphasis on how the cancer cells/tumors evade the immune system (https://www.trialsitenews.com/a/immune-system-evasion-by-viruses-and-tumors-are-we-aiming-at-the-wrong-target-7793c55e). My present study will be a companion to the recent study.
Thank you for this review.
I think we will be safe out here in BC as mask mandates have been reinstated, initially only in "health care" settings.
We don't really have any research to indicate how long the immune changes persist, do we?
Would a detailed genetic assessment reveal the DNA insertions, especially if you studied a subject who had had a previous detailed genome recorded?
For COVID-19 infection spike protein has been detected in blood monocytes (CD16+) for up to 15 months [Patterson BK et al, Frontiers in Immunology, 2022]. No we don't really know how long the changes occur due to vector, especially the SV40 promoter with the nuclear localization signal if integrated into genomic DNA . This is likely to be quite rare (say about 1/250,000) (although not all batches are the same). Dr. Kevin McKernan has a PCR kit that people can buy to test for expression versus integration of the Pfizer vectors. You do not need to have the genome studied beforehand to tell if any of the plasmid sequences or SV40 sequences are there. (The sequence would have to match what is in Pfizer vax). May need to test circulating monocyte/macrophage bone marrow progenitors and stem cells or the cancer cells for these changes. Very few cells in blood but it can be done. On the other hand, can do a 'tumor liquid biopsy' approach for mRNA, cDNA and genomic DNA in plasma. I think the sensitivity could be improved by treating the turbo cancer patient with ivermectin (bolus to rapidly kill lots of turbo cancer cells and the nucleotides released would be in the blood, test a few samples day 1-7, 10 and 15 days to see what day is optimal). Can validate the methodology in a person recently injected with Pfizer C19 vaccine. There is a call to try to raise $$$ to support these investigations (see comments in my last post).